{"id":70806,"date":"2026-08-04T00:46:19","date_gmt":"2026-08-04T00:46:19","guid":{"rendered":"https:\/\/aljabercompany.com\/?p=70806"},"modified":"2026-08-04T00:46:19","modified_gmt":"2026-08-04T00:46:19","slug":"regorafenib-ucinky-a-pouzitie-v-onkologii","status":"publish","type":"post","link":"https:\/\/aljabercompany.com\/index.php\/2026\/08\/04\/regorafenib-ucinky-a-pouzitie-v-onkologii\/","title":{"rendered":"Regorafenib: \u00da\u010dinky a pou\u017eitie v onkol\u00f3gii"},"content":{"rendered":"

Regorafenib je liek, ktor\u00fd sa pou\u017e\u00edva v onkologickej lie\u010dbe na zvl\u00e1danie niektor\u00fdch typov rakoviny. Patr\u00ed do skupiny cielen\u00fdch terapeutick\u00fdch l\u00e1tok a jeho \u00fa\u010dinok spo\u010d\u00edva v inhib\u00edcii viacer\u00fdch prote\u00ednov, ktor\u00e9 s\u00fa d\u00f4le\u017eit\u00e9 pre rast n\u00e1dorov a angiogen\u00e9zu. T\u00fdmto sp\u00f4sobom regorafenib pom\u00e1ha spomali\u0165 progresiu ochorenia a zlep\u0161uje kvalitu \u017eivota pacientov.<\/p>\n

https:\/\/reginas.com.br\/2026\/07\/25\/regorafenib-ucinky-a-pouzivanie-v-onkologii\/<\/a><\/p>\n

\u00da\u010dinky regorafenibu<\/h2>\n

Regorafenib sa vyu\u017e\u00edva v lie\u010dbe r\u00f4znych onkologick\u00fdch ochoren\u00ed, najm\u00e4:<\/p>\n

    \n
  1. Kolorekt\u00e1lny karcin\u00f3m – pou\u017e\u00edva sa u pacientov, ktor\u00ed neodpovedali na in\u00e9 lie\u010debn\u00e9 met\u00f3dy.<\/li>\n
  2. \u017dl\u010dov\u00e9 kan\u00e1liky – pom\u00e1ha v pr\u00edpadoch pokro\u010dil\u00e9ho ochorenia.<\/li>\n
  3. Karciom \u0161t\u00edtnej \u017e\u013eazy – regorafenib m\u00f4\u017ee zmen\u0161i\u0165 ve\u013ekos\u0165 n\u00e1dorov v ur\u010dit\u00fdch situ\u00e1ci\u00e1ch.<\/li>\n
  4. Gastrointestin\u00e1lne stroma – uk\u00e1zal sa ako \u00fa\u010dinn\u00fd pri kontrole progresie n\u00e1dorov.<\/li>\n<\/ol>\n

    Mechanizmus \u00fa\u010dinku<\/h2>\n

    Regorafenib p\u00f4sob\u00ed inhib\u00edciou viacer\u00fdch kin\u00e1z, ktor\u00e9 s\u00fa k\u013e\u00fa\u010dov\u00e9 pre rast n\u00e1dorov. T\u00fdmto ovplyv\u0148uje:<\/p>\n

      \n
    1. Rast n\u00e1dorov\u00fdch buniek<\/li>\n
    2. Vytv\u00e1ranie nov\u00fdch krvn\u00fdch ciev, \u010do je proces naz\u00fdvan\u00fd angiogen\u00e9za<\/li>\n
    3. Interakcie v mikroprostred\u00ed tumoru<\/li>\n<\/ol>\n

      Bezpe\u010dnostn\u00e9 upozornenia a ved\u013eaj\u0161ie \u00fa\u010dinky<\/h2>\n

      Rovnako ako ka\u017ed\u00fd in\u00fd liek, aj regorafenib m\u00f4\u017ee sp\u00f4sobi\u0165 ved\u013eaj\u0161ie \u00fa\u010dinky. Medzi naj\u010dastej\u0161ie patr\u00ed:<\/p>\n

        \n
      1. \u00danava a vy\u010derpanie<\/li>\n
      2. Preru\u0161enie chuti do jedla<\/li>\n
      3. Ko\u017en\u00e9 vyr\u00e1\u017eky a podr\u00e1\u017edenie<\/li>\n
      4. Vysok\u00fd krvn\u00fd tlak<\/li>\n<\/ol>\n

        Pacienti by mali by\u0165 pravidelne monitorovan\u00ed a informovan\u00ed o mo\u017en\u00fdch ved\u013eaj\u0161\u00edch \u00fa\u010dinkoch, aby sa predi\u0161lo z\u00e1va\u017en\u00fdm komplik\u00e1ci\u00e1m.<\/p>\n","protected":false},"excerpt":{"rendered":"

        Regorafenib je liek, ktor\u00fd sa pou\u017e\u00edva v onkologickej lie\u010dbe na zvl\u00e1danie niektor\u00fdch typov rakoviny. Patr\u00ed do skupiny cielen\u00fdch terapeutick\u00fdch l\u00e1tok a jeho \u00fa\u010dinok spo\u010d\u00edva v inhib\u00edcii viacer\u00fdch prote\u00ednov, ktor\u00e9 s\u00fa d\u00f4le\u017eit\u00e9 pre rast n\u00e1dorov a angiogen\u00e9zu. T\u00fdmto sp\u00f4sobom regorafenib pom\u00e1ha spomali\u0165 progresiu ochorenia a zlep\u0161uje kvalitu \u017eivota pacientov. https:\/\/reginas.com.br\/2026\/07\/25\/regorafenib-ucinky-a-pouzivanie-v-onkologii\/ \u00da\u010dinky regorafenibu Regorafenib sa vyu\u017e\u00edva v […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-70806","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/posts\/70806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/comments?post=70806"}],"version-history":[{"count":1,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/posts\/70806\/revisions"}],"predecessor-version":[{"id":70807,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/posts\/70806\/revisions\/70807"}],"wp:attachment":[{"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/media?parent=70806"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/categories?post=70806"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aljabercompany.com\/index.php\/wp-json\/wp\/v2\/tags?post=70806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}